HDAC9 and neoplasm: For example, the HDAC inhibitor suberohydroxamic acid (SBHA) and the PARP inhibitor AG-014699 have been shown to inhibit the function of CHD4 in EpCAM+ liver cancer stem cells52, thereby suppressing tumor growth.